Small amounts of plasma protein normally reach the alveolar epithelial surface by a size-selective process that restricts the passage of very large molecules. Size selectivity may be compromised in the lungs of patients with the adult respiratory distress syndrome (ARDS). To assess this question, bronchoalveolar lavage fluid (BALF) from normal volunteers (n 11), cardiac edema patients (n = 3), and ARDS patients (a = 8) was compared. Mean total protein in ARDS BALF was >12 times the levels in normals or cardiac edema patients. BALF/plasma total protein ratios and measurements of epithelial lining fluid protein also separated the patient groups. The large proteins IgM and a2-macroglobulin were found in ARDS BALF at >90 times the concentrations of normal or cardiac edema fluid. The relationship of distribution coefficient vs. log molecular weight for seven proteins (54,000-900,000 mol wt) hyperbolically increased in normals but was flat in ARDS patients. Sodium dodecyl sulfatepolyacrylamide gel electrophoresis revealed a paucity of high molecular weight proteins in normal and cardiac edema BALF, but demonstrated the full spectrum of plasma proteins in ARDS BALF. We conclude that normal size selectivity is preserved in cardiac edema but is destroyed by the alveolar-capillary injury of ARDS.
Introduction
Alterations in water and solute flux across the endothelial membrane in the pulmonary edema states have been extensively studied in sheep and dog chronic lung lymph fistula models (1) (2) (3) (4) (5) Receivedfor publication 21 March 1985 and in revisedform 24 July 1986.
1. Abbreviations used in this paper: ARDS, adult respiratory distress syndrome; BALF, bronchoalveolar lavage fluid; CBB, Coomassie Brilliant Blue; DC, distribution coefficients; ELF, epithelial lining fluid; F102, inspired oxygen concentration; ICU, intensive care unit; PAGE, polyacrylamide gel electrophoresis; SAB, sample application buffer.
water and protein flux in human pulmonary edema, however, are hindered by the inaccessibility of pulmonary lymph.
In contrast, water and solutes that reach the alveolar epithelial surface can be recovered in humans by aspiration of tracheobronchial edema fluid (6-1 1) or by bronchoalveolar lavage (12) (13) (14) (15) (16) . In the evaluation of human pulmonary edema, Anderson et al. (10) have demonstrated increased clearance of '31I-labeled human albumin from plasma to tracheobronchial fluid in patients with ARDS as compared with patients with cardiac pulmonary edema. Other studies have differentiated these groups of patients using tracheobronchial aspirate/plasma total protein ratios (6) (7) (8) (9) . However, these techniques may not be applicable to all pulmonary edema patients, since they require airway flooding with a sufficient quantity of recoverable alveolar fluid that is uncontaminated by central airway secretions. This limitation might be overcome by the use of segmental bronchoalveolar lavage, a technique that more directly samples alveolar epithelial lining fluid (ELF) (17) .
Although increased protein permeability is well documented in ARDS, little information is available on the distribution of variously sized plasma proteins between blood and ELF in this disorder. ELF obtained from normal subjects contains a spectrum of soluble proteins derived from plasma (12) (13) (14) (15) (16) (17) . Although many of these proteins are quantitatively proportioned as in plasma, very large molecules such as IgM and a2-macroglobulin are much more sparsely distributed to the alveolar surface (15) . In contrast to the normal lung, increased protein permeability in ARDS may be associated with loss of this size restriction so that all plasma proteins are distributed equally between plasma and ELF. In this context, Fowler et al. (18) have demonstrated the presence of fibrinogen and other high molecular weight proteins in ARDS lavage fluid.
In the present study, both groups of pulmonary edema patients and normal volunteers were evaluated by bronchoalveolar lavage. The protein composition of recovered lavage fluid was analyzed by a variety of techniques to answer three questions. First, how do bronchoalveolar lavage fluid (BALF) total protein concentrations and BALF/plasma protein ratios differ in ARDS patients, cardiac pulmonary edema patients, and normal volunteers? Second, how do the pulmonary edema states differ in their distribution of variously sized proteins between plasma and ELF? Third, do BALF protein measurements differentiate human pulmonary edema states more reliably than similar measurements of tracheobronchial secretions?
Methods
Patient groups. The ARDS group (n = 8) consisted of Medical Intensive Care Unit (ICU) patients with noncardiogenic pulmonary edema who were hospitalized between October 1982 and March 1984. All had hy-disease or left ventricular failure; (b) clinical respiratory distress (tachypnea > 20 breaths/min, labored breathing); (c) chest roentgenogram demonstrating diffuse pulmonary infiltrates; (d) physiologic parameters of intrapulmonary shunting (PO2 < 50 mmHg, when inspired oxygen concentration (F102) > 0.6), and normal pulmonary capillary wedge pressure (<15 mmHg). In addition, no patient had bronchoscopic or clinical evidence of airway or parenchymal pyogenic infection. Patients with ARDS due to inhalation of caustic agents (e.g., gastric acid aspiration, noxious fume inhalation) were excluded from the study.
ICU patients with acute cardiogenic pulmonary edema requiring mechanical ventilation comprised one control group (n = 3), hereafter referred to as the cardiac edema group. Diagnostic criteria included: (a) absence of predisposing catastrophic events that might lead to noncardiogenic pulmonary edema; (b) chest roentgenogram demonstrating cardiomegaly and signs of hydrostatic pulmonary edema; (c) right heart catheterization data demonstrating elevated pulmonary capillary wedge pressure (>24 mmHg); and (d) no evidence of airways or lung parenchymal pyogenic infection. A second control group consisted of normal volunteer subjects (n = 11) who had no history of pulmonary disease or cigarette smoking. Written informed consent was obtained from all subjects according to a protocol approved by the Ohio State University Human Subjects Review Committee.
Study design. Patients with pulmonary edema generally underwent bronchoalveolar lavage within 24 h ofintubation. Early study was deemed necessary to minimize potentially confounding factors associated with the ICU setting. These include: (a) airway inflammatory response to bacterial colonization and/or endotracheal trauma in the intubated patient, and (b) the effects of therapeutic interventions such as oxygen toxicity, mechanical ventilation, diuretic and fluid management, and inotropic agents. Bronchoalveolar lavage was repeated at 72-h intervals in those patients who continued to require mechanical ventilation.
Bronchoalveolar lavage. Bronchoalveolar lavage was performed as previously described (14) . After topical lidocaine anesthesia, a 4.8-mm diam flexible fiberoptic bronchoscope (model BF-B2, Olympus Corp. of America, New Hyde Park, NY) was passed through the endotracheal tube of pulmonary edema patients (transnasally in normal volunteers) and wedged into a right middle lobe or lingular subsegment. Five successive 20-ml aliquots of 0.9% saline were instilled and immediately aspirated under low suction.
Lavage fluid processing. BALF samples were strained through monolayers of coarse-mesh surgical gauze and centrifuged at 500 g for 15 min. 1.0 M Tris-HCl (pH 7.4) was added to the decanted supernate to achieve a final concentration of 0.05 M Tris. After passage through a 0.45-,um filter, the cell-free lavage supernates were concentrated by pressure dialysis to 2-3 ml over a YM5 membrane (Amicon Corp., Lexington, MA) and stored at -80°C. (21, 22) . These protein-specific sensitivity differences are substantially diminished when sodium dodecyl sulfate (SDS) is added to the reaction medium. The resulting absolute values strongly correlate with the biuret method, for which differential sensitivity among proteins is minimal (22) . Thus, the Bio-Rad protein microassay procedure (after Bradford) was modified as follows: (a) 2 vol of dye reagent concentrate (Bio-Rad Laboratories, Richmond, CA) (a mixture ofCBB G250, methanol, and phosphoric acid) were gently mixed with 1 vol of 0.024% SDS. (b) 0.3 ml of this mixture was added to 0.7 ml of sample (plasma or concentrated BALF), and the solution was gently mixed by inversion. (c) After incubation at 220C for 15 min, absorbance readings were made at 595 nm on a Beckman DU-8 spectrophotometer. Corresponding protein concentrations were determined from a regression line generated from seven different concentrations of a reference standard (mean correlation coefficient 0.9994±0.0001). The reference standard was prepared from deep-frozen aliquots of a 70-,ug/ ml mixture of 65% bovine serum albumin and 35% gamma globulin (Bio-Rad Laboratories). Each sample was assayed in triplicate at different dilutions and the resultant standard deviation was <5% of the mean for each trio.
BALF total protein concentration refers to micrograms (pg) of protein contained in 1 ml of Tris-buffered cell-free lavage fluid before its concentration over the YM5 membrane (Amicon Corp. In some instances, even YM5-concentrated BALF was too dilute to be quantitated by radial immunodiffusion. After 12-h dialysis against distilled water, these samples were further concentrated by lyophilization and then reconstituted in 20-45 ,d of Tris-saline buffer, depending on the number of assays required. To control for nonspecific protein losses during this secondary processing, a 5-Ml aliquot of the lyophilized preparation was always reserved for repeat triplicate total protein assay. Repeat protein assay of these samples ensured accurate concentration ratios of component protein to total protein, which were necessary for determination of DC.
ELF measurements. Measurements of ELF provided information about the dilutional effects of bronchoalveolar lavage. For the measurement of ELF volumes and proteins, additional ARDS patients (n = 5) and normal volunteers (n = 10) were evaluated by an identical bronchoalveolar lavage procedure. Measurement of ELF was accomplished by the urea dilution method described by Rennard et al. (17) . This method assumes that the small molecule urea is freely diffusible between plasma and ELF. Therefore, urea measurements in simultaneous plasma and BALF samples allow for calculation of ELF volume (milliliters) and expression as a percentage of BALF (ml ELF/ 100 ml BALF). ELF concentrations oftotal protein and albumin were calculated for each patient group.
Estimation of alveolar-capillary membrane protein permeability.
BALF total protein concentration was used as an index of alveolarcapillary membrane permeability (23) . A concentration ratio of BALF total protein to plasma total protein (8ALF/plasma) was calculated for each patient and expressed as the ratio X 100. In additional patients, protein permeability was estimated by ELF total protein concentration and ELF/plasma total protein ratios.
Permeability ofproteins ofvarious molecular weights. The presence Statistical methods. Data are expressed as the mean±SEM. The significance ofintergroup differences was assessed by nonparametric analysis (Wilcoxon's (24) rank sum test for independent samples) because measured parameters could not be assumed to be normally distributed. The null hypothesis was rejected at the 0.05 level. Data cited from other publications mentioned in the Discussion section were similarly analyzed (Table IV) .
Results
Table I displays the relevant physiologic data of the pulmonary edema patients at the time ofthe initial lavage, which was within 24 h of intubation for five of eight ARDS patients and for all three cardiac edema patients. As expected, ARDS patients had significantly lower values for pulmonary capillary wedge pressure (P < 0.05) than cardiac edema patients. ARDS patients also had lower values for static lung compliance (P < 0.05). The mean alveolar-arterial oxygen pressure difference was higher in ARDS patients but not significantly different from cardiac edema patients. Seven of eight ARDS patients survived, compared with one of three cardiac edema patients.
Bronchoalveolar lavage was well tolerated by all patient groups. 20 such procedures were performed on the eight ARDS patients. 8 of these represented the initial evaluation of each ARDS patient and the other 12 represented serial studies performed on six of the patients. Examination of the airways at bronchoscopy revealed no evidence of purulent secretions or blood. There were no significant differences in percent recovery (Table II) .
Serial bronchoalveolar lavage studies. Six ARDS patients were evaluated with serial bronchoalveolar lavage. Analysis of the serial data provided information about the time course of the permeability alterations, as well as their relationship to gas exchange abnormalities (Fig. 2) . During the first 5 d of ARDS, every BALF/plasma total protein ratio remained at least two times as high as the highest cardiac edema or normal volunteer BALF/plasma ratio (Fig. 2, top) . There was a gradual downward trend in the BALF/plasma ratio with time, and the ARDS ratios approximated those ofthe control groups by day 7. Serial BALF/ plasma ratios were also compared with changes in gas exchange as assessed by the alveolar-arterial oxygen pressure difference (Fig. 2, bottom which contained 25.8±8.3 ug/ml of a2-macroglobulin and 10.3±2.9 ttg/ml ofIgM (Fig. 3) . In contrast, these proteins could not be measured by radial immunodiffusion in normals unless the BALF was further concentrated by lyophilization. Using simultaneously measured total protein to extrapolate these values back to unconcentrated BALF, normal BALF contained 0.24±0.05 ug/ml of a2-macroglobulin and 0.1 1±0.02 ,gg/ml of IgM (Fig. 3) . Thus, ARDS BALF contained >90-fold concentrations ofboth proteins compared with normal BALF (P < 0.01, both comparisons). Even after lyophilization, a2-macroglobulin could not be detected in cardiac edema BALF. IgM was 0.14 ,ug/ml in one of the cardiac edema patients. In the other two cardiac edema patients, IgM immunodiffusion precipitin rings were visible but were below the lower limit of quantification.
DCfor individual serum proteins. Since ARDS BALF contained markedly increased concentrations of protein, including high molecular weight proteins, it appeared that the permeability defect of ARDS was associated with destruction of the normal size-restrictive property of the alveolar-capillary membrane. (Fig. 4) (Fig. 5) . Virtually all plasma bands in each patient could also be identified in the matched BALF protein profile. Interestingly, some bands present in BALF were not seen in plasma, and most likely represented products of the intense local inflammatory response.
When normal and ARDS BALF protein profiles were compared by PAGE, the ARDS profile consistently contained a spectrum of higher molecular weight protein bands not visible in normal BALF, even though equal amounts of total protein were loaded (Fig. 6) 
Discussion
Protein permeability ofthe pulmonary microcirculation has been extensively studied in animal lung lymph fistula models which trace the transendothelial movement of protein from plasma to pulmonary lymph (1) (2) (3) (4) (5) . Such models have demonstrated increased lymph flow rates in both types of pulmonary edema. Lymph/plasma protein concentration ratios, however, drop to about half of baseline after induction of cardiac edema (3) but remain unchanged or increase slightly after induction of permeability edema (2) . Since evaluation of pulmonary lymph is not clinically feasible in man, similar assessment of the pulmonary edema states in humans has depended on techniques that recover alveolar lining fluid. Since this fluid is normally separated from interstitial lymph by an epithelial cell interface, one would expect its protein composition to be further modulated by epithelial permeability characteristics specific to the edema-forming process. Indeed, the protein content of tracheobronchial aspirates of human edema fluid has been used to differentiate cardiac pulmonary edema from permeability pulmonary edema (ARDS) (6-1 1). However, a potential problem with this method is contamination of pulmonary edema fluid by central airway exudate. In the present study, we hypothesized that bronchoalveolar lavage would collect a more representative alveolar sample and thus allow for better characterization of epithelial protein permeability in human pulmonary edema. We present evidence that the protein content of BALF and BALF/ plasma protein ratios can be used to unequivocally separate ARDS patients from heart failure patients and normal controls. We have further demonstrated that the increased protein permeability of ARDS is associated with a loss of the normal sizeselective access of plasma protein to the alveolar epithelial surface.
Protein permeability ofthe normal alveolar capillary membrane. The normal pulmonary parenchymal barrier that separates air from blood is composed of endothelial, interstitiallymphatic, and epithelial compartments. Each ofthe three compartments is endowed with traits that protect against alveolar flooding (25) (6) (7) (8) (9) . The chief criterion for entry into these studies was pulmonary edema of sufficient magnitude to allow collection of several milliliters of edema fluid from the airways. The data in Table IV has been compiled from patients in the above cited studies in whom (a) edema fluid and plasma protein values were known, and (b) pulmonary capillary wedge pressure measurements and clinical diagnosis suggested the existence of either hydrostatic or permeability mechanisms, but not both. Nonparametric analysis reveals statistically significant differences in mean bronchial aspirate protein levels of cardiac edema and ARDS groups, although there is considerable overlap of ranges. Much better separation ofthe ranges occurs when edema/plasma protein ratios are compared, where the mean ratio in ARDS patients is roughly twice that of cardiac edema patients. In contrast, the BALF data in the present study reveals logfold differences in means and widely separated ranges whether BALF protein concentrations alone or BALF/plasma ratios are examined.
The finding that BALF protein analysis provides better separation ofpatient groups than tracheobronchial protein analysis suggests that the latter technique samples alveolar edema fluid mixed with variable proportions of central airway secretions. In this context, the numerous bronchial irritants that accompany mechanical ventilation (such as high inspired oxygen concentrations, bacterial colonization, secretion stasis, and suction catheter and endotracheal tube trama) probably lead to serous exudation from the endobronchial wall. This may well be enhanced by the high capillary hydrostatic pressures of cardiac edema. Mixed with alveolar edema fluid, this serous exudate would raise the protein concentration ofcardiac edema bronchial aspirate but not significantly alter the already exudative protein concentrations ofARDS aspirate. The true proportion ofalveolar protein could thus be widely variable. Conversely, contamination with airway exudate is likely to be insignificant with a "wedged" bronchoalveolar lavage procedure because (a) the dependent secretions that would be harvested by bronchial aspirate are not only bypassed by the bronchoscope, but are unlikely to contaminate the nondependent right middle lobe (or lingula) site of lavage; and (b) should bronchial exudate form at the subsegmental level, its contribution to total protein would be dwarfed by that of the exponentially larger alveolar surface.
The excellent separation of patient groups by BALF protein analysis was supported by ELF measurements. In the present study, bronchoalveolar lavage of normal volunteers yielded 0.95±0.06 ml ELF/100 ml BALF with ELF albumin concentrations of 4.6±0.6 mg/ml. These values are very similar to the data reported by Rennard et al. (17) (1.0±0.1 ml, 3.7±0.3 mg/ ml), and support the conclusion that ELF albumin concentrations are 10% of plasma values. In ARDS patients, ELF volumes were increased approximately eightfold, and ELF total protein values were 25% of plasma values. Thus ELF/plasma total protein ratios clearly separate ARDS patients from normal subjects (0.25 compared with 0.13). The urea method is subject to error if appreciable amounts of urea are diffused into the lavage fluid from plasma during the brief time of the lavage. This potential source of error would appear to be minimal since the present study followed the same protocol as Rennard et al. (17) , in which five 20-ml aliquots were instilled and immediately withdrawn. The urea method has not previously been used in ARDS patients, and it remains theoretically possible that the flux of urea from plasma to instilled saline lavage fluid occurs at a faster rate in ARDS patients compared with normals. In this case, the urea method would overestimate the volume of ARDS ELF and thus underestimate the calculated ELF protein concentrations. Therefore, in the present study, differences between ARDS and normal ELF/plasma protein ratios may represent minimum values.
